ENANTA PHARMACEUTICALS INC

Pharmaceutical Preparations | SIC: 2834
Phone: 617 607 0800
CIK: 0001177648
EIN: 043205099
State Location: MA
Tickers:
  • Nasdaq:ENTA

Form: 8-K

Filing Date: 11 Aug 2025
Report Date: 11 Aug 2025
Accepted: 11 Aug 2025 06:15 p.m.
Accession Number: 0001193125-25-177941
Act: 34
File Number: 001-35839
Film Number: 251202189
Items: 2.02,9.01

Documents

Primary Document: 8-K
Accepted: 11 Aug 2025 06:15 p.m.